MarketCap
Facebook
X
Telegram
Cabaletta Bio Balance Sheet 2025-2011 | CABA
Brief overview of Cabaletta Bio's balance sheet structure
Balance sheet changes are traced across five available annual reports between 2021 and 2025.
Over the period, assets gained +30.7%, moving from $126.3 million to $165.1 million. CAGR near 6.9% shows consistent growth.
Liability growth of +532.8% exceeded asset growth of +30.7%, increasing reliance on outside funding.
The equity-to-assets ratio is 67.9%, compared with 93.4% five periods ago. The balance sheet has a substantial internal cushion.
The balance sheet holds more cash than interest-bearing debt; net debt is -$76.6 million, indicating minimal leverage.
The cash share moved from 96.7% to 50.3%. A higher figure generally provides more room in an adverse scenario.
The accumulated result is -$517 million and remains below zero. The number alone does not explain whether losses, dividends or repurchases were the main cause.
Overall assessment
Cabaletta Bio's financial position is more positive than negative: the funding mix is workable, although the cushion is not unlimited.
Annual Balance Sheet Cabaletta Bio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-76.6 M | -157 M | -188 M | -76.5 M | - | -101 M | -136 M | -33 M | -1 K | - | - | - | - | - | - |
Long Term Debt |
2.88 M | 3.24 M | 1.46 M | 2.96 M | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
3.46 M | 3.99 M | 3.56 M | 2.18 M | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | 43.9 M | - | - | - | - | - | - | - |
Total Current Liabilities |
50.2 M | 27.1 M | 16 M | 9.49 M | 8.38 M | 5.18 M | 3.15 M | - | - | - | - | - | - | - | - |
Total Liabilities |
53 M | 32.7 M | 17.5 M | 12.4 M | 8.38 M | 5.18 M | 3.15 M | 44.9 M | 250 K | - | - | - | - | - | - |
Retained Earnings |
-517 M | -349 M | -233 M | -166 M | -113 M | -66.3 M | -33 M | -12.5 M | -250 K | - | - | - | - | - | - |
Total Assets |
165 M | 185 M | 254 M | 117 M | 126 M | 115 M | 141 M | 34.2 M | 1 K | - | - | - | - | - | - |
Cash and Cash Equivalents |
83 M | 164 M | 193 M | 81.6 M | 122 M | 101 M | 136 M | - | - | - | - | - | - | - | - |
Book Value |
112 M | 152 M | 236 M | 105 M | 118 M | 110 M | 138 M | -10.7 M | -249 K | - | - | - | - | - | - |
Total Shareholders Equity |
112 M | 152 M | 236 M | 105 M | 118 M | 110 M | 138 M | -10.7 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Cabaletta Bio
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
3.33 M | 4.56 M | 3.9 M | 8.1 M | 3.24 M | 7.29 M | - | 765 K | 1.46 M | 1.75 M | 2.01 M | 2.49 M | 2.96 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
44.8 M | 50.3 M | 46 M | 43.6 M | 32.7 M | 30.2 M | 17.9 M | 18.7 M | 17.5 M | 12.4 M | 10.5 M | 11.8 M | 12.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-560 M | -475 M | -430 M | -385 M | -349 M | -317 M | -286 M | -258 M | -233 M | -212 M | -196 M | -181 M | -166 M | -150 M | -138 M | -126 M | -113 M | -98.7 M | -87.1 M | -76 M | -66.3 M | -66.3 M | -66.3 M | -66.3 M | -33 M | -33 M | -33 M | -33 M | -12.5 M | -12.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
148 M | 190 M | 224 M | 165 M | 185 M | 204 M | 217 M | 240 M | 254 M | 173 M | 185 M | 103 M | 117 M | 91.7 M | 102 M | 114 M | 126 M | 123 M | 107 M | 107 M | 115 M | 115 M | 115 M | 115 M | 141 M | 141 M | 141 M | 141 M | 34.2 M | 34.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
117 M | 60.2 M | 146 M | 132 M | 164 M | 171 M | 179 M | 175 M | 193 M | 116 M | 128 M | 93.8 M | 81.6 M | 61.2 M | 47.2 M | 59.6 M | 122 M | 118 M | 99.5 M | 97.3 M | 101 M | 101 M | 101 M | 101 M | 136 M | 136 M | 136 M | 136 M | 33 M | 33 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
103 M | 139 M | 178 M | 122 M | 152 M | 174 M | 200 M | 222 M | 236 M | 161 M | 174 M | 91.7 M | 105 M | 91.7 M | 102 M | 114 M | 126 M | 123 M | 107 M | 107 M | 115 M | 115 M | 115 M | 115 M | 141 M | 141 M | 141 M | 141 M | 34.2 M | 34.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
103 M | 139 M | 178 M | 122 M | 152 M | 174 M | 200 M | 222 M | 236 M | 161 M | 174 M | 91.7 M | 105 M | 85.9 M | 95.5 M | 107 M | 118 M | 117 M | 101 M | 103 M | 110 M | 110 M | 110 M | 110 M | 138 M | 138 M | 138 M | 138 M | -10.7 M | -10.7 M | -1.14 M | - | -249 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Balance Sheet is a fundamental financial report of Cabaletta Bio, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Canada
China
USA
France
Singapore
Britain
Germany
Israel
Russia
Belgium
Irlanda
